An open study of the safety and efficacy of enoxacin in complicated urinary tract infections
| Autor: | Gordon Williams, M. Roe, S. Want, M. Foot, S. Bates, G. Quaghebeur |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Adult
Enoxacin Male Microbiology (medical) medicine.medical_specialty Nausea Urinary system Urine medicine.disease_cause Enterococcus faecalis Streptococcal Infections Internal medicine Escherichia coli medicine Humans Pseudomonas Infections Pharmacology (medical) Naphthyridines Adverse effect Aged Pharmacology biology business.industry Pseudomonas aeruginosa Enterobacteriaceae Infections Middle Aged biology.organism_classification Anti-Bacterial Agents Surgery Infectious Diseases Urinary Tract Infections Vomiting Drug Evaluation Female medicine.symptom business medicine.drug |
| Zdroj: | Journal of Antimicrobial Chemotherapy. 21:97-103 |
| ISSN: | 1460-2091 0305-7453 |
| DOI: | 10.1093/jac/21.suppl_b.97 |
| Popis: | Thirty-one patients with serious or complicated urinary tract infections were treated with oral enoxacin for between four and eight days. Twenty-five patients with microbiologically confirmed infections completed treatment with 400 mg enoxacin twice daily and at the end of treatment all urine cultures were negative. At short term follow-up, five to nine days after therapy, 21 of the 25 patients were still infection free. In total, reinfection or relapse occurred in 12 patients during the four to six weeks follow up period after termination of treatment. Significant side-effects (nausea and vomiting) occurred in only one patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|